With a new Alzheimer’s drug, it’s is the company everyone is talking about. Is it the real deal? » Subscribe to CNBC: » Watch more …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More